J&J analyst day tries to steer focus to drug business as talc baby powder comes under fire

  • 📰 CNBC
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

Business News News

Business Business Latest News,Business Business Headlines

Johnson & Johnson's pharmaceutical business will take the spotlight Wednesday at the company's analyst day as the company shares its plans for the next few years and tries to allay investors' concerns over talc-based baby powder.

J&J CEO Alex Gorsky told CNBC the company needs to focus on new innovations.Alex Gorsky, CEO of Johnson & Johnson's pharmaceutical business will take the spotlight Wednesday at its annual meeting with analysts as the company tries to allay investors' concerns over its talc-based baby powder.

J&J plans to launch 10 new drugs by 2023, the company announced Wednesday. CEO Alex Gorsky said the company needs to stay focused despite the litigation. The company faces thousands of lawsuits alleging its talc baby powder products contain asbestos and caused ovarian cancer and mesothelioma. Ain December said J&J knew for decades that its baby powder contained asbestos, a story the company called "an absurd conspiracy theory."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines